Roop K. Lakkaraju - 05 Sep 2025 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
EVP, Chief Financial Officer
Signature
/s/ Roop K. Lakkaraju
Issuer symbol
BIO
Transactions as of
05 Sep 2025
Net transactions value
-$162,486
Form type
4
Filing time
09 Sep 2025, 16:23:38 UTC
Previous filing
25 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lakkaraju Roop Kalyan EVP, Chief Financial Officer C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE, HERCULES /s/ Roop K. Lakkaraju 09 Sep 2025 0001396867

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO BIO.B Bio-Rad A Common Stock Options Exercise $0 +1,535 +179% $0.000000 2,394 06 Sep 2025 Direct F1, F2
transaction BIO BIO.B Bio-Rad A Common Stock Tax liability $162,486 -550 -23% $295.43 1,844 06 Sep 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIO.B Restricted Stock Units Award $0 +5,480 $0.000000 5,480 05 Sep 2025 Bio-Rad A Common Stock 5,480 $0.000000 Direct F3, F4
transaction BIO BIO.B Restricted Stock Units Options Exercise $0 -1,535 -25% $0.000000 4,608 06 Sep 2025 Bio-Rad A Common Stock 1,535 $0.000000 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Includes 13.2750 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2025.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4 The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.